Index
Grant ZQ0NP6JQgZ
Verdictconfirmed95%
1 check · 4/29/20261 → confirmed
Our claim
entire record- Name
- VasoRX — Operating Costs
- Amount
- $280,000
- Currency
- USD
- Date
- October 2024
- Notes
[Scientific Research] Open Philanthropy recommended an investment of $280,000 in VasoRX, a company that has discovered and patented a novel lipid nanoparticle capable of delivering RNA interference medication specifically to the vascular endothelium without targeting other tissue… expand
[Scientific Research] Open Philanthropy recommended an investment of $280,000 in VasoRX, a company that has discovered and patented a novel lipid nanoparticle capable of delivering RNA interference medication specifically to the vascular endothelium without targeting other tissues such as liver. The company has also discovered that the technology can be used in combination with a specific RNA to reverse pulmonary hypertension and atherosclerosis in preclinical models. This falls within our focus area of scientific research.
Source evidence
1 src · 1 checkconfirmed95%deterministic-row-match · 4/20/2026
- Name
- VasoRX — Operating Costs
- Grantee
- VasoRX
- Focus Area
- Scientific Research
- Amount
- $280,000.00
- Date
- October 2024
- Description
- Open Philanthropy recommended an investment of $280,
NoteDeterministic match: grantee, amount, date matched in source snapshot (2714 rows)
Case № ZQ0NP6JQgZFiled 4/29/2026Confidence 95%